相似文献
1
The relationship between TIGIT regulatory T cells and autoimmune disease.
Int Immunopharmacol. 2020 Jun;83:106378. doi: 10.1016/j.intimp.2020.106378. Epub 2020 Mar 12.
2
TIGIT A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.
J Autoimmun. 2020 Jul;111:102441. doi: 10.1016/j.jaut.2020.102441. Epub 2020 Mar 20.
3
Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
Front Immunol. 2018 May 3;9:907. doi: 10.3389/fimmu.2018.00907. eCollection 2018.
4
A2Ar-dependent PD-1+ and TIGIT+ Treg cells have distinct homing requirements to suppress autoimmune uveitis in mice.
Mucosal Immunol. 2023 Aug;16(4):422-431. doi: 10.1016/j.mucimm.2023.04.005. Epub 2023 May 9.
5
Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells.
Commun Biol. 2023 May 9;6(1):500. doi: 10.1038/s42003-023-04874-3.
6
FCRL3 expression is upregulated and closely correlates with TIGIT expression in regulatory T cells of patients with systemic lupus erythematosus.
Eur J Immunol. 2024 May;54(5):e2350739. doi: 10.1002/eji.202350739. Epub 2024 Mar 10.
7
Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.
J Immunol. 2015 Apr 15;194(8):3687-96. doi: 10.4049/jimmunol.1401803. Epub 2015 Mar 11.
8
Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice.
Immunology. 2013 Jun;139(2):179-86. doi: 10.1111/imm.12065.
9
Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.
Immunol Lett. 2020 Sep;225:1-8. doi: 10.1016/j.imlet.2020.06.003. Epub 2020 Jun 12.
10
DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.
Int Immunol. 2021 Nov 25;33(12):687-692. doi: 10.1093/intimm/dxab085.
引用本文的文献
1
The homeostasis and heterogeneity of regulatory T cells in sepsis.
Burns Trauma. 2025 Jul 15;13:tkaf047. doi: 10.1093/burnst/tkaf047. eCollection 2025.
2
Negative Immune Checkpoint Inhibitors.
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
3
CTLA-4 expression on tregs is needed for suppression of autoimmune uveitis.
Sci Rep. 2025 May 22;15(1):17745. doi: 10.1038/s41598-025-02816-z.
4
Cell-Based Therapeutic Strategies for Autoimmune Diseases.
Immunotargets Ther. 2025 Apr 28;14:501-514. doi: 10.2147/ITT.S513629. eCollection 2025.
5
Advance in chimeric antigen receptor T therapy in autoimmune diseases.
Front Immunol. 2025 Mar 4;16:1533254. doi: 10.3389/fimmu.2025.1533254. eCollection 2025.
6
Single-cell RNA sequencing elucidates cellular plasticity in esophageal small cell carcinoma following chemotherapy treatment.
Front Genet. 2025 Jan 9;15:1477705. doi: 10.3389/fgene.2024.1477705. eCollection 2024.
7
High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells.
Mol Ther Methods Clin Dev. 2024 Nov 18;32(4):101385. doi: 10.1016/j.omtm.2024.101385. eCollection 2024 Dec 12.
8
Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective.
Front Immunol. 2024 Sep 23;15:1461756. doi: 10.3389/fimmu.2024.1461756. eCollection 2024.
9
Exploring the Common Pathogenic Mechanisms of Psoriasis and Atopic Dermatitis: The Interaction between SGK1 and TIGIT Signaling Pathways.
Inflammation. 2024 Aug 1. doi: 10.1007/s10753-024-02115-1.
10
Regulatory T Cells: Therapeutic Opportunities in Uveitis.
Front Ophthalmol (Lausanne). 2022 May 25;2:901144. doi: 10.3389/fopht.2022.901144. eCollection 2022.
本文引用的文献
1
OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB Signaling.
J Immunol. 2019 Dec 15;203(12):3225-3236. doi: 10.4049/jimmunol.1900530. Epub 2019 Nov 8.
2
Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation.
Int Immunopharmacol. 2019 Dec;77:105971. doi: 10.1016/j.intimp.2019.105971. Epub 2019 Oct 31.
3
Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.
Front Immunol. 2019 Apr 30;10:835. doi: 10.3389/fimmu.2019.00835. eCollection 2019.
4
Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.
Mediators Inflamm. 2019 Mar 17;2019:8450947. doi: 10.1155/2019/8450947. eCollection 2019.
5
Treatment of murine lupus with TIGIT-Ig.
Clin Immunol. 2019 Jun;203:72-80. doi: 10.1016/j.clim.2019.04.007. Epub 2019 Apr 18.
6
Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4 Treg Cells in Patients with Rheumatoid Arthritis.
Cell Physiol Biochem. 2019;52(5):1178-1192. doi: 10.33594/000000080.
7
Bach2 Controls T Follicular Helper Cells by Direct Repression of Bcl-6.
J Immunol. 2019 Apr 15;202(8):2229-2239. doi: 10.4049/jimmunol.1801400. Epub 2019 Mar 4.
8
Human FOXP3 Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer.
Immunity. 2019 Feb 19;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020.
9
TIGIT signaling restores suppressor function of Th1 Tregs.
JCI Insight. 2019 Feb 7;4(3):e124427. doi: 10.1172/jci.insight.124427.
10
EomesT-bet CD8 T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia.
Cancer Res. 2019 Apr 1;79(7):1635-1645. doi: 10.1158/0008-5472.CAN-18-3107. Epub 2019 Feb 1.
Zotero 插件